Vous n'êtes pas connecté
Astria to present at upcoming Bradykinin Symposium Astra Therapeutics announced that it will present two posters at the upcoming Bradykinin Symposium in Berlin, Germany on 6 September 2024: Chris Morabito, M.D., Chief Medical Officer at Astria Therapeutics, will present information on ALPHA-SOLAR, a long-term open-label trial of navenibart (STAR-0215) in people living with HAE, [...]